ALD

Orphan designation: 5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride Treatment of adrenoleukodystrophy, 18/11/2016 Positive

Retrieved on: 
Sunday, February 4, 2024
Hearing, Inflammation, Civil service commission, Knowledge, European, Cell, Haematopoiesis, COMP, IRIS, Bone marrow, Mitochondrion, Adrenal insufficiency, Regulation, Gland, ABCD1, Patient, Safety, Diagnosis, EMA, ALD, European Commission, Adrenoleukodystrophy, Seizure, B cell, PPAR, Brain, Disease, Therapy, Eurostat, Tissue, Dementia, Medicine, Committee, Hormone, DSM-IV codes, Spinal cord, Pharmaceutical industry

Orphan designation: 5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride Treatment of adrenoleukodystrophy, 18/11/2016 Positive

Key Points: 


Orphan designation: 5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride Treatment of adrenoleukodystrophy, 18/11/2016 Positive

Ponce De Leon Foundation Announces Grant Awards

Retrieved on: 
Monday, January 29, 2024
Case management, Housing, Little Sisters, LEAP, Access, Family Legal Care, ACE, Mental health, Literacy, Organization, History, POTS, Opportunity, CDC, ALD, HOPE, Owner-occupancy, Education, Comment, Survivor, LGBT Network, Digital literacy, Fast food

BRONX, N.Y., Jan. 29, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of the Ponce De Leon Foundation is pleased to announce it has awarded $622,000 to nonprofits that are making a difference in our communities.

Key Points: 
  • BRONX, N.Y., Jan. 29, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of the Ponce De Leon Foundation is pleased to announce it has awarded $622,000 to nonprofits that are making a difference in our communities.
  • Since its inception in 2017, the Foundation has provided over $2.3 million in grants.
  • Madeline V. Marquez, Executive Director of the Ponce De Leon Foundation, stated “each year the number of applications to our grant program grows by a lot.
  • Act Now Foundation, Inc.: $16,000 for the Alzheimer’s Care Project.

Hitachi Construction Machinery Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 10, 2024
Other Construction & Property, Machinery, Construction & Property, Manufacturing, ALD, Artificial intelligence, Big data, Hitachi, HCM, Risk, Welding, Acquisition, ICT, Evaluation, 3D, Safety, Robotics, Data analysis, Automation, CAD, FMS, Internet of things, Universal design

The "Hitachi Construction Machinery - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hitachi Construction Machinery - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering.
  • This report provides insight into Hitachi Construction Machinery's digital strategies, including its digital transformation strategies, its innovation programs, its technology initiatives, its estimated ICT budget, and its major ICT contracts.
  • THCM is one of the largest construction equipment manufacturers in India and has manufacturing facilities in Kharagpur and Dharwad.
  • It helps HCM in maintaining a stable supply of construction machinery products that provide safe and durable performance for customers.

Goeroptics unveils its latest optical solutions at CES 2024, driving technological innovation in VR/AR displays

Retrieved on: 
Thursday, January 11, 2024
ALD, 2D, Ghosting, Noise, Research, Incidence, PVD, DLP, XR, Electronics, HUD, Risk, COC, SRG, 3D, Virtual reality, VR, CES, DLPC, Liquid crystal on silicon, Lens, FOV, AA, PGU, Television

In a collaborative effort with 3M, Goeroptics applied the COC co-molding technique to the module, marking its first application in this context.

Key Points: 
  • In a collaborative effort with 3M, Goeroptics applied the COC co-molding technique to the module, marking its first application in this context.
  • Compared with the conventional 3D film lamination process, Star M41 incorporates 3M's latest film into the mold to enable simultaneous injection.
  • The comprehensive range of solutions delivers precision optical measurement, automated component assembly and options for optical system design.
  • It boasts strong capabilities in designing, developing and manufacturing XR optical lenses, optical imaging modules, DLP projectors, and automotive HUD components.

Tauber-Arons Inc. and Aaron Industrial Solutions Announce Timed Online Auction of Assets of a Premier Metal 3D Printing Company and Powder Producer in Northern California

Retrieved on: 
Thursday, January 11, 2024
Online, ALD, Powder, Metal, Auction

A Timed Online Auction is set to take place on Wednesday, February 07, with bidding commencing at 11:00 AM.

Key Points: 
  • A Timed Online Auction is set to take place on Wednesday, February 07, with bidding commencing at 11:00 AM.
  • Pre-Auction offers are being accepted on all major items, and for the facility in its entirety up until Feb. 1, 2024.
  • This auction presents an unparalleled offering of state-of-the-art Powdered Metals Processing and Printing Facilities, featuring an impressive array of extremely late model equipment.
  • "We are excited to facilitate this groundbreaking auction, showcasing the latest advancements in Powdered Metals Processing and Printing Facilities.

Veteran Mom Says Marine Son Was Miracle Child

Retrieved on: 
Tuesday, December 5, 2023
Fisher House, Genetic testing, Meal, Travel, Adrenoleukodystrophy, Army, Hospital, Brain, ALD, Hatboro, Pennsylvania, Behavior, Transport, Diagnosis, DSM-IV codes, USS Harry S. Truman

Rockville, MD, Dec. 05, 2023 (GLOBE NEWSWIRE) -- If you talk to Army veteran Pat Sherrod-Elliott about her son, Marine Sgt.

Key Points: 
  • Rockville, MD, Dec. 05, 2023 (GLOBE NEWSWIRE) -- If you talk to Army veteran Pat Sherrod-Elliott about her son, Marine Sgt.
  • It took months at hospitals in Charleston, South Carolina and Bethesda, Maryland to get a diagnosis.
  • People born with ALD usually do not make it through childhood, which is what made Sean’s case a miracle.
  • “He loved God, loved his country, loved being a Marine, and he was a beloved father.

Three New Articles in the Journal of Pharmaceutical Analysis Demonstrate the Potential of Natural Compounds to Treat Gastrointestinal Disorders

Retrieved on: 
Tuesday, November 28, 2023
Hepatitis, MEFV, Dave's Picks Volume 13, Hope, Pneumonia, Liver, HSP90, Panax notoginseng, Macrophage, Mouse, Journal, Colitis, Metabolism, Ulcerative colitis, Ethanol, GI, NLRP3, SNZ, ALD, UC, JPA, Pharmaceutical industry

XI'AN, China, Nov. 28, 2023 /PRNewswire/ -- Chronic gastrointestinal (GI) disorders are becoming increasingly common throughout the world, but many of them still lack effective treatment. Researchers have now turned to natural compounds, such as those present in traditional medicines, to search for potential drug candidates for difficult-to-treat diseases. The latest issue of the Journal of Pharmaceutical Analysis (JPA) features three articles that report promising findings and could pave the way to treatments for complex diseases affecting the liver and intestine. 

Key Points: 
  • Researchers have now turned to natural compounds, such as those present in traditional medicines, to search for potential drug candidates for difficult-to-treat diseases.
  • The latest issue of the Journal of Pharmaceutical Analysis (JPA) features three articles that report promising findings and could pave the way to treatments for complex diseases affecting the liver and intestine.
  • The article was available online in July 2023 and published in Volume 13, Issue 9 of JPA in September 2023 .
  • Moreover, Rk2 also restored intestinal barrier function by enhancing NLPR6 signaling in the intestine, demonstrating its multifaceted therapeutic potential.

ClassOne Technology Receives Order for Solstice® S8 Single-Wafer System from Finland’s VTT Technical Research Centre

Retrieved on: 
Thursday, November 9, 2023
MEMS, 3D, ALD, VTT, US, Classon Avenue station, Copper, Organization, Research, VTT Technical Research Centre of Finland, SRD, University, AP, TSV, Automation, SIP, Solstice, Printed circuit board, Mobile phone

KALISPELL, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ClassOne Technology , a leading global provider of advanced electroplating and wet processing tools for microelectronics manufacturing, today announced that leading European research institution VTT Technical Research Centre of Finland has placed its first order for a ClassOne Solstice® S8 single-wafer system.

Key Points: 
  • KALISPELL, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ClassOne Technology , a leading global provider of advanced electroplating and wet processing tools for microelectronics manufacturing, today announced that leading European research institution VTT Technical Research Centre of Finland has placed its first order for a ClassOne Solstice® S8 single-wafer system.
  • Dominant packaging technologies flip-chip, 2.5D/3D and system-in-package (SiP) are expected to represent 90% of the AP market by 2028.
  • Noted ClassOne Technology CEO Byron Exarcos, “We welcome VTT as a new customer for our Solstice platform.
  • Please visit us to learn more about our Solstice single-wafer platform as well as our Trident™ batch processing systems.

Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023

Retrieved on: 
Wednesday, November 8, 2023
Biotechnology, Pharmaceutical, Health, Adrenoleukodystrophy, Patient, Serono, ALD, Plasma, AMN, Patent, Biomarker, Sumitomo Pharma, Diabetes, Merck, SGLT2, Jaguar 3.4 Litre, EPO, Pharmacokinetics, Male, DPP4, Disease, Prescription, Marshal of France, Pioglitazone, European Patent Office, EUR, United States patent law, Merck Serono, VLCFA, Safety, European Patent Convention, JPY, Estonia, Kidney, POC, Pharmaceutical industry, Imeglimin

Sumitomo Pharma has worked diligently to increase the production and secure inventory capacity to meet this increasing demand.

Key Points: 
  • Sumitomo Pharma has worked diligently to increase the production and secure inventory capacity to meet this increasing demand.
  • For the Sumitomo Pharma FY 2023, as a conservative assumption in line with Sumitomo Pharma’s forecast, Poxel expects to receive 8% royalties on TWYMEEG net sales.
  • On July 5th, Poxel was chosen as the winner of the 2023 edition of the I-nov contest for its program in ALD.
  • Next Financial Press Release: Fourth Quarter 2023 Cash and Revenue update, on February 15, 2024

MSP Unveils Turbo II™ Vaporizers

Retrieved on: 
Monday, November 6, 2023
CVD, Science, TCO, MSP, ALD, Vapor pressure, Maintenance, Life, Propane

Shoreview, MN, Nov. 06, 2023 (GLOBE NEWSWIRE) -- MSP, a Division of TSI®, is thrilled to announce the launch of the new line of MSP Turbo II™ Vaporizers .

Key Points: 
  • Shoreview, MN, Nov. 06, 2023 (GLOBE NEWSWIRE) -- MSP, a Division of TSI®, is thrilled to announce the launch of the new line of MSP Turbo II™ Vaporizers .
  • Inspired by breakthroughs in the science of droplet atomization and evaporation, these innovative vaporizers are half the physical footprint of earlier versions, while delivering a staggering 200% increase in vapor output.
  • Elevate your CVD and ALD processes to unparalleled heights with the MSP Turbo II™ Vaporizers.
  • For further information or to request your Turbo II™ Vaporizer, visit tsi.com/MSP-Turbo-II/ or contact our sales team.